South Africa's Aspen plans to buy infant nutritional business from Nestle
JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare (APNJ.J) has plans to buy Nestle South Africa's infant nutritional business for $215 million, the company said on Thursday.
The deal gives it certain rights to intellectual property licenses, net assets and shares currently conducted by Pfizer.
(Reporting by Sherilee Lakmidas)
(The story corrects value of acquisition)